“…High doses of MDMA also cause neurotoxicity through increased glutamate levels (Sarkar & Schmued, 2010), oxidative stress (Fiaschi & Cerretani, 2010; Sarkar & Schmued, 2010), and ischemia/vasoconstriction (Baker et al, 2007; Bingham et al, 1998). Similarly, NIHL is associated with neural toxicity from reduced adenosine levels (Vlajkovic et al, 2009), reduced nicotinic acetylcholinergic activity (Elgoyhen et al, 2009), reduced glucocorticoid receptor activity (Jin et al, 2009), increased glutamate release (Le Prell et al, 2007), oxidative stress (Le Prell et al, 2007), ischemia in the stria vascularis (Le Prell et al, 2007), and serotonin and dopamine depletion (Lendvai et al, 2011; Papesh & Hurley, 2012; Tong et al, 2005). …”